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Introduction
The excitatory neurotransmitter glutamate activates α-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors, N-
methyl-D-aspartate (NMDA) receptors and kainate receptors. Fast
excitatory transmission in the brain is mainly mediated by AMPA
receptors (AMPARs), and its dynamic alteration is thought to be
involved in several cognitive processes, including learning and
memory.
One of the most extensively studied models of activity-dependent
plastic changes in synaptic strength is long-term potentiation (LTP),
which is thought to be crucial for learning and memory. NMDA-
type receptors (NMDARs) are important for the induction of LTP,
which involves long-lasting changes in synaptic strength caused by
activity-dependent modulation of AMPAR-mediated transmission
(Malenka and Bear, 2004). In the course of LTP generation, high-
frequency stimuli activate AMPARs and NMDARs, leading to
subsequent changes in trafficking of AMPARs to the synapse (Barry
and Ziff, 2002; Bredt and Nicoll, 2003; Collingridge et al., 2004).
Several scaffolding proteins are known to regulate AMPAR
trafficking, including the transmembrane AMPAR-regulatory
proteins (TARPs), the ATPase N-ethylmaleimide-sensitive factor
(NSF), members of the membrane-associated guanylate kinase
protein-family (MAGUKs) and other PDZ-domain-containing
proteins, such as the glutamate receptor-interacting protein (GRIP)
or the protein kinase C α (PKCα)-binding protein PICK1. Stargazin
(CCG2) and γ-8 (CCG8) are members of the TARP family and were
shown to be essential for the surface expression and clustering of
AMPARs at synapses (Nicoll et al., 2006). Stargazin-deficient mice
lack synaptic AMPARs in cerebellar granule cells, but show normal
synaptic transmission in the hippocampus (Chen et al., 2000). In
γ-8-knockout mice, hippocampal synaptic transmission and
plasticity are reduced (Rouach et al., 2005). Overexpression of the
MAGUK PSD95 increases AMPAR-mediated transmission (Beique
and Andrade, 2003; Ehrlich and Malinow, 2004; Nakagawa et al.,
2004; Schnell et al., 2002), and PSD93 PSD95 double-knockout
mice show a severe impairment in fast excitatory transmission (Elias
et al., 2006). GRIP, NSF and PICK1 interact directly with the
cytoplasmic tail of the GluR2 subunit of AMPARs (Kim et al., 2001;
Luthi et al., 1999; Setou et al., 2002).
The founding member of the protein 4.1 family, 4.1R (official
mouse protein symbol, Epb4.1), was originally identified as a
stabilizer of erythrocyte shape, connecting the transmembrane
protein glycophorin C (GLPC) and the MAGUK p55 with the
spectrin cytoskeleton (Marfatia et al., 1995). In addition to 4.1R,
AMPA-type glutamate receptors mediate fast excitatory synaptic
transmission in the vertebrate brain. Their surface expression
at synapses between neurons is regulated in an activity-
dependent and activity-independent manner. The protein
machinery that regulates synaptic targeting, anchoring and
turnover of AMPA receptors consists of several types of
specialized scaffolding proteins. The FERM domain scaffolding
proteins 4.1G and 4.1N were previously suggested to act jointly
in binding and regulating synaptic trafficking of the AMPA
receptor subunits GluR1 and GluR4. To determine the functions
of 4.1G and 4.1N in vivo, we generated a mutant mouse line that
lacks 4.1G entirely and expresses 4.1N at 22% of wild-type levels.
These mice had combined 4.1G and 4.1N protein expression in
the hippocampus at 12% of wild-type levels (equivalent to 8-
10% of combined GluR1 and GluR4 expression levels). They
show a moderate reduction in synaptosomal expression levels of
the AMPA receptor subunit GluR1 at 3 weeks of age, but no
change in basic glutamatergic synaptic transmission and long-
term potentiation in the hippocampus. Our study indicates that
4.1G and 4.1N do not have a crucial role in glutamatergic
synaptic transmission and the induction and maintenance of
long-term plastic changes in synaptic efficacy.
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the 4.1 family includes the members 4.1B (Epb4.1L3), 4.1G
(Epb4.1L2) and 4.1N (Epb4.1L1). All four 4.1 proteins share a
highly conserved domain structure characterized by the presence
of an N-terminal FERM (four point one, ezrin, radixin, moesin)
domain, a spectrin-actin-binding domain and a C-terminal domain,
all of which interact with multiple transmembrane proteins. The
ability of 4.1 proteins to bind very structurally diverse interaction
partners via their different protein domains enables them to
participate in many different physiological processes in a variety
of cell types and tissues.
Proteins 4.1G and 4.1N have been shown to be expressed in
neuronal and non-neuronal cells in the brain (Lu et al., 2004; Ohara
et al., 2000; Ohno et al., 2005). Protein interactions with the GluR1
and GluR4 subunits of AMPARs were described for the MAGUK
SAP97 and the 4.1 proteins 4.1N and 4.1G (Cai et al., 2002;
Coleman et al., 2003; Rumbaugh et al., 2003; Shen et al., 2000).
The Drosophila 4.1 protein homologue coracle interacts with
GluRIIA (Chen et al., 2005) and binding of 4.1N and 4.1G is
suggested to regulate surface expression of GluR1 and GluR4
(Coleman et al., 2003; Shen et al., 2000).
In the present study, we examined the role of the 4.1 paralogues
4.1G and 4.1N in hippocampal neurotransmission and synaptic
plasticity using mutant mice in which combined 4.1N and 4.1G
protein expression in the hippocampus is reduced to 12% of wild-
type levels, which is equivalent to 8-10% of combined GluR1 and
GluR4 expression levels.
Results
Targeting of the mouse 4.1G and 4.1N genes
The 4.1G and 4.1N double-mutant (4.1G/N) mice (abbreviated as
DKO in figures) were generated by a conditional mutagenesis
strategy. In both cases, two LoxP sites flanking the first coding exon
and a neomycin-resistance gene flanked by frt sites were introduced
by homologous recombination in embryonic stem cells (129/ola) (Fig.
1A,D). A fragment representing bp 25,131,023-25,131,494 on band
A3 of Chromosome 10 and bp 1-471 in the 4.1G mRNA (AJ542537)
was floxed in the mouse 4.1G gene Epb41l2 (GeneID 13822). The
4.1N gene Epb41l1 (GeneID 13821) is located on band H2 of
Chromosome 2. The region representing bp 156,185,360-156,185,551
in the 4.1N gene and bp 206-396 in 4.1N mRNA (AF061283) was
floxed. Of 192 screened embryonic stem (ES) cell clones in both
cases, nine clones with the desired 4.1G recombination and 15 clones
with the desired 4.1N recombination were identified by Southern blot
analysis with a 5 external probe (probe 1 for 4.1G, Fig. 1A; probe
2 for 4.1N, Fig. 1D). Two ES cell clones of each gene were injected
into C57BL/6 blastocysts. The offspring of chimeric males and
subsequent generations were genotyped by PCR (Fig. 1C,F,G). The
resulting recombinant single 4.1G+/– and 4.1N+/– mice were bred with
EIIaCre deleter mice (Lakso et al., 1996), which resulted in the loss
of the first coding exon in both cases (Fig. 1G). The 4.1G-knockout
mice were then crossed with 4.1N mutant mice to breed 4.1G/N
double-mutant animals. The offspring were bred to homozygosity
and selected for the absence of the Cre transgene.
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Fig. 1. Targeting of genes encoding 4.1G and 4.1N. (A,D) Schematic representations of the mouse 4.1G and 4.1N genomic loci, targeting vectors, targeted alleles,
and excision of the first coding exon by Cre recombinase. LoxP sites are indicated by grey triangles, the neomycin selection cassette is flanked by frt sites (black
arrowheads) for possible excision by flip recombinase. Ex, exon. (A) Targeting strategy for gene encoding 4.1G. The first coding exon has been excised. The
positions of AccI restriction sites and the 5 Southern probe (Probe 1) are shown. (B) Southern blot analysis of 4.1G. Probe P1 was used for hybridisation. The
signal for the 4.1G WT allele resulted in a 6598 bp band and the recombinant allele resulted in a 4569 bp band. (C) Genotyping of 4.1G WT and mutant mice by
PCR. In 4.1G WT animals primers p1 and p2 generated a 144 bp band. In recombinant alleles and after Cre recombination a 408 bp fragment is synthesized with
primers p3 and p4. (D) Targeting strategy for gene encoding 4.1N. The first coding exon has been excised. The positions of ScaI restriction sites and the 5
Southern probe (Probe 2) are marked. (E) Southern blot analysis with Probe 2 after ScaI digestion of stem cell DNA. The introduction of the neomycin selection
cassette resulted in an additional ScaI restriction site and a shift of the 8904 bp WT band to a 4471 bp band. (F,G) Genotyping of 4.1N mutants. Genotyping of
mouse tail DNA with primers p5 and p6 resulted in a 243 bp WT band and no band was synthesized after knockout of 4.1N (F). In genomic PCRs with primers p7












737Role of 4.1G and 4.1N in synaptic transmission
Anatomy and cage behaviour of 4.1G/N double mutants
Neither single mutants nor homozygous 4.1G/N double mutants
showed obvious phenotypic alterations. The 4.1G/N double-mutant
mice were born at the expected mendelian frequency, and no gross
behavioural abnormalities were apparent. The life spans were similar
to those of control animals (data not shown).
Examination of the double-mutant animals by MRI using T1-
and T2-weighted images showed only slight changes in the gross
anatomy of the brain in 3-week-old animals (Fig. 2A). Quantitative
volumetric analyses revealed mild, although significant, reductions
in whole brain volume and cerebellar volume in young 4.1G/N
double-mutant mice (Fig. 2C,D). These changes seem to be
compensated during development, as they were absent in 7-month-
old double-mutant mice (Fig. 2B-E).
Immunohistochemical staining was performed to determine the
number of matched and mismatched pre- and postsynaptic
components of glutamatergic synapses in the stratum radiatum of
hippocampal CA1 area of 4.1G/N double mutants and wild-type
(WT) controls at the age of 3 weeks. Neither the spatial distribution
nor the densities of puncta positive for VGLUT1/VGLUT2,
ProSAP1 or both were altered significantly in 4.1G/N double-mutant
hippocampus (Fig. 3A,B). Moreover, the ultrastructure of synapses
formed in double-mutant animals was indistinguishable from that
of WT controls (Fig. 3C). Mature synaptic specializations were
observed in the CA1 region of 3-week-old mice in both the mutant
and WT animals. Synaptic parameters, such as the number of
synapses per 100 μm2, the length of the postsynaptic density and
the width of the postsynaptic density, were similar in both groups
(Fig. 3D) (WT, n=3; DKO, n=3). Taken together, these data indicate
that the expression of proteins 4.1G and 4.1N is not critical for
proper formation of glutamatergic synapses.
Expression of 4.1 proteins in 4.1G/N double-mutant mice
Western blot analyses confirmed that 4.1G was completely absent
in 4.1G/N double-mutant mice (Fig. 4A), whereas the short variant
of two 4.1N isoforms was still present (Fig. 4B; Fig. 5B,C), albeit
reduced to a level of 30% of that in control preparations (Fig. 5D).
The level of 4.1B protein was unchanged in the 4.1G/N double-
mutant animals (supplementary material Fig. S1). The ratio between
the short and the long variant of 4.1N in the hippocampus is 2.6±0.7
(n=6, calculated based on a densitometric analysis of the data shown
in Fig. 5B,C). Thus, a 70% reduction of the short form of 4.1N and
a complete elimination of the long 4.1N variant in our mutants is
equivalent to a 78% reduction of total 4.1N expression in the
hippocampus of 4.1N/G double-mutant mice. The ratio between
4.1N and 4.1G protein expression is 1:0.78 in rat total hippocampus
(Yamakawa and Ohara, 2000) and 1:0.94 in mouse hippocampus
postsynaptic density preparations (Trinidad et al., 2008). Thus, the
reduction of combined 4.1G/N protein expression in our
homozygous double-mutant hippocampus is estimated to be 88-89%
compared with WT controls.
To deduce the primary structure of the residually expressed 4.1N
isoform, we performed western blot analyses with three domain-
specific antibodies: anti-4.1N exon 2 directed against the first 15
amino acids encoded by exon 2, anti-4.1N monoclonal antibody
(BD Biosciences), which is specific for a region of the spectrin-
actin-binding domain, and an anti-CTD antibody against the C-
terminal domain of 4.1N (Fig. 5E). Fig. 5A shows that the anti-
Fig. 2. Anatomical differences in young 4.1G/N
double-mutant mice are compensated during
development. (A) Anatomical 3D MRI at age 3 weeks.
T1-weighted (upper panel) and T2-weighted (lower
panel) horizontal sections from 3D MRI data sets of
WT and 4.1G/N double-mutant (DKO) mice reveal no
obvious differences in overall brain morphology (n=4,
for WT and DKO). (B) 3D MRI of adult mice. T1-
weighted (upper panel) and T2-weighted (lower panel)
horizontal sections from 3D MRI data sets of WT and
4.1G/N double-mutant mice reveal no obvious
differences in overall brain morphology (n=3, for WT
and DKO). (C) Quantitative in vivo MRI volumes
based on the images shown in A, error bars indicate
s.d. The whole-brain volume was significantly
reduced in the 4.1G/N double mutants at the age of 3
weeks (**P=0.0074, determined by Student’s t-test)
but not in adult mutants. (D) The cerebellar volume
was significantly reduced in the 4.1G/N double
mutants at the age of 3 weeks (*P=0.039, determined
by Student’s t-test, error bars indicate s.d.) but not in
adult mutants. (E) The ventricle volume was not














4.1N exon 2 antibody detected only the upper band in the WT,
whereas in the 4.1G/N double-mutant mice, no signal was
recognized at all (n=3). By contrast, the anti-4.1N monoclonal
antibody and the anti-4.1N CTD antibodies detected two bands in
the WT, whereas only the lower band was identified in the 4.1G/N
double mutants (n=3) (Fig. 5B,C).
To characterize the residual 4.1N splicing variant in the 4.1G/N
double mutants, we combined RACE (rapid amplification of cDNA
ends) experiments and database analyses. The disappearance of the
lower WT 4.1N band in western blots stained with the anti-4.1N
exon 2 antibody (Fig. 5A, left panel) indicated an alternative use
of the first coding exon, as previously reported for 4.1R and 4.1B
(Conboy, 1991; Gascard, 2004). There are indications of alternative
start codon use in human (NM_177966) and equine
(XM_001501911) 4.1N mRNA, but no corresponding 4.1N mRNA
or ESTs could be identified for the mouse.
To define the full brain-specific use of 4.1N exons in WT and
4.1G/N double mutants, we generated 5RACE and 3RACE
transcript sequences (Fig. 5G). All transcripts cloned
experimentally by 5RACE from WT (12 clones) included exon
2. Exon 3 never contributed to the 5RACE sequences in the WT.
The 3 RACE-PCRs generated two different populations of
transcripts. Four of nine clones encoded the high molecular weight
class of 4.1N including exon 17B. The other five clones
corresponded to the lower 4.1N form. To our surprise, in the
4.1G/N double mutants all 5RACE-PCR transcripts (nine clones)
started with exon 3, which is usually removed from mature mRNA,
and the first initiation codon was localized in exon 4. All 3RACE
PCR clones from the 4.1G/N double mutants lacked exon 17A
and exon 17B. As the anti-4.1N exon 2 peptide antibody is directed
against the first 15 amino acids of the N-terminus, it is possible
that this epitope is not accessible for the antibody in the WT 4.1N
short variant. The absence of a band in the 4.1G/N double mutants
can be explained by the genetic knockout of exon 2, which includes
the epitope of the anti-4.1N exon 2 antibody. We conclude from
the results obtained by western blots and RACE experiments that
the residually expressed protein in 4.1G/N double mutants is
similar to the short form expressed in the WT, but differs in its
N-terminal sequence.
Next, we determined expression levels of GluR1, GluR2/3,
GluR4 and NR1 in young adult 4.1G/N double-mutant mice by
quantitative western blot analyses of synaptosome preparations from
Journal of Cell Science 122 (5)
Fig. 3. Synaptic morphology in the hippocampus of 4.1G/N double-mutant mice. (A) Properly aligned pre- and postsynaptic specializations in stratum radiatum of
hippocampal area CA1. The left panel shows representative micrographs of the CA1 area of control (WT, n=3) and 4.1G/N double-mutant (DKO, n=3) sections
after double labeling for glutamatergic excitatory postsynapses (stained for ProSAP1, red) and presynapses (stained for VGLUT1/2, green). Scale bars: 8 μm.
(B) Quantification of isolated and colocalized ProSAP1 and VGLUT1/2 puncta in the CA1 region of control (WT, white, n=3) and 4.1G/N double-mutant mice
(DKO, grey, n=3). The total numbers of synapses were not significantly different in the two experimental groups. Error bars indicate s.d. (C,D) Ultrastructural
analysis of CA1 neurons in 4.1G/N double-mutant mice and WT controls at the age of 3 weeks. Mature synaptic specializations were observed in both groups;
quantification was performed in the stratum radiatum. The number of synapses per 100μm2 and the length and the width of PSDs were similar in both












739Role of 4.1G and 4.1N in synaptic transmission
whole-brain homogenates (Fig. 6A). Here, we found significantly
reduced synaptic GluR1 protein levels in synaptosomes from
4.1G/N double-mutant mice (WT, n=6; DKO, n=6; **P<0.01).
Furthermore, we measured GluR1, GluR2/3 and GluR4
concentrations in Triton-X-100-insoluble postsynaptic density
(PSD) preparations of hippocampi obtained from young adult
4.1G/N double-mutant mice and WT controls. Supporting our
findings in synaptosomes, we found significant changes in the levels
of the GluR1 subunit (Fig. 6B) (WT, n=7; DKO, n=7; *P<0.05).
GluR2/3 levels were also significantly decreased in PSD
preparations, although a direct interaction between 4.1G or 4.1N
and GluR2/3 has not been described. In vivo, AMPARs usually
form heteromers composed of different subunits. A reduction in the
GluR1 subunit might therefore be accompanied by a reduction of
other GluR subunits such as GluR2/3.
Synaptic and extrasynaptic AMPAR responses are normal in
young 4.1G/N double-mutant mice
The Schaffer collateral synapses in the hippocampus are very well
characterized with respect to their short- and long-term synaptic
plasticity. It is generally accepted that the induction of long-term
potentiation (LTP) in area CA1 is NMDAR dependent (Malenka
and Bear, 2004). A leading hypothesis states that LTP in area CA1
is activity dependent and relies on insertion of AMPARs as
GluR1/GluR2-containing receptors are driven into the synapses after
the induction of LTP (Hayashi et al., 2000).
Fig. 4. Expression pattern of 4.1G and 4.1N in WT and 4.1G/N double-mutant brains. (A) Western blot analysis using a 4.1G-specific antibody detecting an epitope
located within the first coding exon. 4.1G is expressed in all examined regions of the central nervous system (upper panel). OB, olfactory bulb; CX, cortex; CPu,
striatum; Hi, hippocampus; Thal, thalamus; Hthal, hypothalamus; Co, colliculus; Cb, cerebellum; BS, brain stem; SpC, spinal cord. No signal was detected in
4.1G/N double-mutant mice (lower panel). (B) Western blot analysis using the 4.1N monoclonal antibody. 4.1N is expressed in all examined brain regions with
minor expression in BS and SpC. The short variant of the two 4.1N isoforms was still present at low levels in the 4.1G/N double-mutant animals.
Fig. 5. Residual expression of a shorter 4.1N form in the 4.1G/N
double-mutant hippocampus. (A-C) Hippocampal preparations from 3-
week-old WT (left panel) or 3-week-old 4.1G/N double mutant (right
panel) were loaded and stained on western blots with the following
antibodies. (A) Anti-4.1N exon 2, which is directed against the first 15
amino acids of the N-terminus; (B) Anti-4.1N monoclonal antibody,
which recognizes a C-terminal region of the spectrin-actin-binding
domain; (C) Anti-4.1N CTD, which is detecting the very C-terminus of
4.1N. (D) Densitometric quantification of data pooled from B and C.
The error bars indicate s.e.m. **P<0.01; ***P<0.001; Student’s t-test.
(E) Schematic representation of the murine full-length 4.1N protein.
The positions of the epitopes of the antibodies used in A-C are
indicated. U1, unique region 1; FERM, Four-point-one, ezrin, radixin,
moesin homology domain; FA, FERM adjacent region; U2, unique
region 2; SABD, spectrin-actin-binding domain; U3, unique region 3;
CTD, C-terminal domain. Unique regions are shown in yellow,
conserved areas are in blue. (F) Exon usage map of the mouse 4.1N
gene in brain. Numbering is derived from mouse Epb41l1 as described
(Ramez et al., 2003). The colour code is modelled on the domain
structure shown in E. Dotted boxes denote nontranscribed exons. The
positions of the specific 5RACE primers and the specific 3RACE
primers are indicated by arrows. (G) Schematic representation of the













As 4.1 proteins were shown to interact with the GluR1 subunit
and because we found a reduction of GluR1 expression in
synaptosomes of 4.1G/N double-mutant mice (Fig. 6A), we tested
whether the loss of protein 4.1G together with the strong reduction
of protein 4.1N leads to alterations in synaptic transmission and
changes in LTP in young adult 4.1G/N double mutants. To measure
synaptic responses in hippocampal brain slices of 4.1G/N double-
mutant mice, we stimulated the Schaffer collaterals in area CA1
and recorded postsynaptic field potentials (fEPSPs) in the stratum
radiatum of area CA1. Comparing the size of the presynaptic afferent
volley (representative of presynaptic excitability), with the slope
of the fEPSP (representing postsynaptic responsiveness), we found
no significant differences in the fEPSP slopes at various afferent
volley amplitudes (WT, n=10; DKO, n=13) (Fig. 7A). Using
whole-cell patch-clamp recordings, we found that the ratio of
AMPAR- to NMDAR-mediated excitatory postsynaptic current
(EPSC) is not altered in 4.1G/N double mutants (AMPA/NMDA
ratio: WT, 4.8±0.9, n=13; DKO, 6.1±1.1, n=11; P=0.39; AMPAR-
mediated EPSC: WT, 241±20 pA; DKO, 281±26 pA, P=0.23;
NMDAR-mediated component: WT, 66±10 pA; DKO, 54±9 pA,
P=0.35) (Fig. 7B).
Paired-pulse facilitation (PPF) is a form of short-term plasticity
and generally assumed to be of presynaptic origin. Using a paired-
pulse stimulation protocol, the second response is facilitated
compared with the first response within a short time-window.
Using different stimulation intervals varying from 50 mseconds
to 500 mseconds, we found that PPF in field recordings is not
significantly changed in 4.1G/N double mutants (WT, 1.44±0.06,
n=7; DKO, 1.39±0.03, n=10; P=0.4). Whole-cell recordings
confirmed these data at an interstimulus interval of 50 mseconds
(WT PPF, 1.47±0.07, n=15; DKO PPF, 1.47±0.04, n=15; P=0.97)
(Fig. 7C,D). We also recorded miniature EPSCs (mEPSCs) in
the presence of the sodium channel blocker tetrodotoxin (TTX,
1 μM) and the AMPAR desensitization inhibitor cyclothiazide
(CTZ, 100 μM). AMPAR-mediated mEPSCs showed neither a
difference in frequency nor a difference in amplitude recorded
at –60 mV between WT and 4.1G/N double-mutant animals. The
mean mEPSC frequency was 0.9±0.1 Hz in WT mice and 1.2±0.1
Hz in 4.1G/N double mutants (WT, n=5; DKO, n=9; P=0.11) and
the mean amplitude of the AMPAR-mediated mEPSCs was 18±2
pA in WT animals and 16±1 pA in 4.1G/N double-mutant mice
(Fig. 8) (P=0.31). In summary, basal synaptic properties of
Journal of Cell Science 122 (5)
Fig. 6. GluR levels are altered in 4.1G/N double-mutant mice.
(A) Reduced GluR1 levels in whole brain synaptosomal
preparations. Protein levels in synaptosomal fractions of 3-week-old
mice expressed as percentage of WT levels. Error bars indicate s.d.
(WT, n=6; DKO, n=6; **P<0.01). (B) Reduced GluR1 and GluR2/3
levels in PSD preparations from young adult hippocampi. Protein
levels are expressed as percentage (± s.d.) of WT levels (WT, n=7;
DKO, n=7; *P<0.05).
Fig. 7. Synaptic responses in area CA1 in WT and 4.1G/N double-
mutant mice. (A) Input-output curves for basal synaptic
transmission in area CA1 of the hippocampus. Sample traces are
shown for the input (fiber volley) and the output (fEPSP). No
significant difference was found between WT and 4.1G/N double
mutants in the fEPSP slopes at various afferent volley amplitudes
(WT, n=10; DKO, n=13). (B) Ratio of AMPA and NMDA currents
is not altered in 4.1G/N double mutants (AMPA/NMDA ratio: WT,
n=13; DKO, n=11). Sample traces from CA1 pyramidal cells are
shown. (C) Paired-pulse facilitation (PPF) is unchanged in 4.1G/N
double-mutant mice. PPF in field recordings is not significantly
changed in double-mutant mice at intervals varying from 50
mseconds to 500 mseconds (WT, n=7; DKO, n=10). (D) Whole-
cell recordings from CA1 pyramidal cells do not reveal differences
in PPF between WT and 4.1G/N double mutants at an
interstimulus interval of 50 mseconds (WT, n=15; DKO, n=15).












741Role of 4.1G and 4.1N in synaptic transmission
AMPARs are not significantly changed in 4.1G/N double-mutant
mice.
Next, we tested for alterations in the biophysical properties of
AMPAR-mediated currents by measuring the rectification index,
which was not significantly different between WT and 4.1G/N
double-mutant neurons (2.8±0.4, n=6 and 2.7±0.4, n=6, respectively,
P=0.8) (see supplementary material Fig. S2). Also, pharmacological
challenging of AMPARs with the relatively selective GluR2
antagonist Naphthyl-acetyl-spermine (100 μM) revealed no
differences in the slope of fEPSP recordings between the two
genotypes (WT slope, 97.7±0.5% of control; DKO slope, 99.0±3%
of control, n=4). The effectivity of the drug was confirmed by EPSC
recordings from interneurons, where a substantial amplitude
reduction was observed (see supplementary material Fig. S3). We
thus did not find any indication for a change in AMPAR subunit
composition in 4.1G/N double-mutant neurons.
As it is known that 4.1 proteins interact with AMPARs, we tested
whether extrasynaptically located AMPAR are altered in 4.1G/N
double-mutant mice. In the presence of TTX and CTZ, we bath-
applied S-AMPA (100 nM) for 5 minutes and recorded the whole-
cell current. By this procedure AMPARs are activated in the synaptic
cleft, on the dendrites and on the somata. Application of S-AMPA
led to a robust inward current of approximately 400-500 pA in WT
and 4.1G/N double-mutant cells, with no significant differences
between the tested genotypes (WT, 510±47 pA, n=4; DKO, 462±51
pA, n=5; P=0.52) (Fig. 9). Taken together, these results show that
neither synaptic nor extrasynaptic AMPAR function is affected in
4.1G/N double mutants.
Long-term potentiation is normal in young 4.1G/N double-
mutant mice
We studied long-term synaptic plasticity in WT and 4.1G/N double-
mutant mice using field potential recordings. After recording stable
fEPSPs in area CA1 for 10-20 minutes, the Schaffer collaterals were
stimulated tetanically (four 1-second trains of 100 Hz, separated
by 20 seconds). LTP was stable for 30-40 minutes after the tetanic
stimulation in WT and 4.1G/N double mutants. No significant
differences between WT and 4.1G/N double-mutant mice were
found in the fEPSP slope 30-40 minutes after induction of LTP (Fig.
10) (WT, 137±6%, n=10; DKO, 135±7%, n=11; P=0.8). These data
show that neither basal synaptic transmission nor short-term or long-
term plasticity are altered in 4.1G/N double-mutant mice.
Discussion
In the present study, we used 4.1G/N double-mutant mice to assess
the role of proteins 4.1G and 4.1N in glutamate receptor trafficking
and synaptic anchoring, in hippocampal synaptic transmission and
in synaptic plasticity. We found that (1) in young adult mice the
GluR1 expression levels in 4.1G/N double mutants are reduced in
synaptosomal and PSD fractions (Fig. 6); (2) GluR2/3 expression
levels in 4.1G/N double mutants are reduced in PSD fractions (Fig.
6); (3) AMPAR-mediated glutamatergic synaptic transmission in
Fig. 8. mEPSCs recorded from CA1 pyramidal neurons in WT and 4.1G/N
double-mutant animals. (A,B) Miniature EPSCs (mEPSCs) were recorded in
the presence of the sodium channel blocker tetrodotoxin (TTX, 1 μM) and the
AMPAR-desensitization inhibitor cyclothiazide (CTZ, 100 μM). mEPSCs
showed no change in frequency (A) or amplitude (B). (C) Recordings of WT
and 4.1G/N double mutants cells at –60 mV (for details see text). A cumulative
frequency distribution of mEPSCs amplitudes is shown in (A). n.s., not
significant.
Fig. 9. Extrasynaptic AMPA currents are not reduced in 4.1G/N double-mutant
mice. (A,B) Whole-cell currents evoked by bath application of 100 nM
AMPA. A single example is shown in A and a summary plot in B. AMPA was
applied for 5 minutes in the presence of 100 μM cyclothiazide and 1 μM TTX.
(C) Maximal AMPA whole-cell current is not altered in 4.1G/N double














4.1G/N double mutants is not changed (Figs 7-9), which is not
consistent with the previously published notion that proteins 4.1G
and 4.1N bind GluR1 and tether it to the postsynaptic cytoskeleton
(Shen et al., 2000); and (4) LTP at CA3-CA1 Schaffer collaterals
in 4.1G/N double mutants is not altered (Fig. 10), which argues
against a crucial role of proteins 4.1G and 4.1N in the activity-
dependent insertion of GluR1-containing AMPARs into potentiated
synapses (Hayashi et al., 2000).
The two AMPA receptor subunits that were shown to bind 4.1
proteins, GluR1 and GluR4, bind to both 4.1N and 4.1G (Shen et
al., 2000; Coleman et al., 2003). Thus, 4.1N and 4.1G can be
viewed to have a joint role in GluR1 and GluR4 trafficking. Our
knockout strategy eliminated 4.1G expression entirely and 4.1N
expression very strongly. The combined 4.1N/G protein expression
in double-mutant hippocampus was reduced to 11-12% of WT
levels. If 4.1G and 4.1N acted jointly as crucial stoichiometric
interaction partners and scaffold proteins of GluR1 and GluR4
under normal circumstances, the residual expression of 4.1N in
the 4.1G/N double-mutant mice is unlikely to be sufficient for the
maintenance of normal function, because the relative expression
levels of 4.1G, 4.1N, GluR1 and GluR4 in mouse hippocampus
are 0.89-0.99, 0.95-1.05, 1.48-1.61, and 0.87-0.95, respectively
(Trinidad et al., 2008). Thus, total deletion of 4.1G and a reduction
of 4.1N expression by 78% would lead to a massively sub-
stoichiometric ratio between combined 4.1G and 4.1N, and
combined GluR1 and GluR4 expression in mouse hippocampus
of at least 0.08:1, and 0.1:1, at most. Such a massive deficiency
of 4.1G and 4.1N expression compared with GluR1 and GluR4
expression in the double-mutant hippocampus would be expected
to have severe functional consequences on glutamatergic
transmission if 4.1G and 4.1N had a crucial role in GluR1 and
GluR4 trafficking and anchoring, but our data show that this is
not the case.
The fact that GluR1 levels are reduced in 4.1G/N double mutants
supports the notion that proteins 4.1G and 4.1N bind GluR1 and
stabilize it (Shen et al., 2000). However, the finding that neither
basal AMPAR-mediated synaptic transmission nor synaptic
plasticity in the hippocampus are altered in 4.1G/N double mutants
makes an essential role of proteins 4.1N and 4.1G in the trafficking,
function, and dynamics of AMPARs in vivo rather unlikely. This
lack of phenotypic changes in 4.1G/N double mutants is either due
to the fact that previously published in vitro experiments on the
role of 4.1G and 4.1N in GluR1 trafficking and anchoring detected
cell-culture specific phenotypes that are not relevant in vivo, or is
caused by the fact that multiple AMPAR scaffold proteins operate
in parallel at synapses and can substitute for the loss of the two
scaffold proteins studied here. We favour the latter notion, as
outlined below.
Striking functional redundancy has been reported for other
postsynaptic AMPAR scaffold protein families that have been
studied in detail. Targeted truncation of PSD95 in mutant mice, for
example, does not affect AMPAR-mediated synaptic transmission
in the hippocampus (Migaud et al., 1998). Similarly, single deletions
of PSD95 or PSD93 do not cause functional changes in basal
synaptic transmission (Elias et al., 2006). Only the simultaneous
deletion of both PSD93 and PSD95 leads to marked reductions in
glutamatergic synaptic transmission (Elias et al., 2006). By contrast,
individual knockdown of either PSD93 or PSD95 using an shRNA
strategy causes impaired glutamatergic transmission in hippocampal
slice cultures (Elias et al., 2006). These findings indicate that PSD93
and PSD95 are functionally redundant and can compensate for the
loss of the other MAGUK if sufficient time is available for these
compensatory mechanisms to take place, as is the case in the deletion
mutant mice, but apparently not when the proteins are knocked down
by shRNAs.
Two recent studies found the interaction of stargazin and other
TARPs with AMPARs to be the most robust and least transient
compared with other putative interactions, including those with 4.1
proteins (Fukata et al., 2005; Vandenberghe et al., 2005). Indeed,
TARPs function as auxiliary subunits of AMPARs and are important
determinants of AMPAR trafficking and synaptic anchoring. An
80-90% reduction in hippocampal AMPAR protein levels and a 30-
40% reduction in synaptic transmission are observed in γ-8-
knockout mice, and extrasynaptic AMPARs were also reduced by
80-90% (Rouach et al., 2005). Similarly, cerebellar granule cells
from mice lacking Stargazin lack synaptic and extrasynaptic
AMPARs (Chen et al., 2000). These data show that γ-8 and Stargazin
determine AMPAR stability and synaptic recruitment. Furthermore,
the data obtained from γ-8-deficient mice indicate that even strong
reductions in overall AMPAR levels do not cause similarly severe
reductions in synaptic AMPAR function. This apparent lack of a
linear correlation between overall AMPAR levels and AMPAR
function at synapses might explain why, in the case of the 4.1G/N
double-mutant mice described here, a 20-30% reduction of GluR1
levels at postsynapses does not cause a concomitant reduction of
synaptic transmission in the hippocampus.
In summary, the present study indicates that proteins 4.1G and
4.1N are generally dispensable for proper function of glutamatergic
Journal of Cell Science 122 (5)
Fig. 10. LTP is not impaired in 4.1G/N double-mutant animals. (A) Depicted
are representative results from WT (open circles) and 4.1G/N double-mutant
(filled circles) animals. LTP was induced by tetanic stimulation, i.e. 100 pulses
at 100 Hz, four 4 times, 20 seconds apart. Traces on top of the graph are
averages of 7-10 consecutive responses each, taken from control and at the end
of the recording period. (B) Summary plot of 10 experiments in WT and 11
experiments in 4.1G/N double-mutant mice. No differences in synaptic
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synapses in vivo. Data obtained in in vitro studies on these proteins
can therefore not be directly extrapolated to the in vivo situation.
It is likely that the lack of phenotypic changes in glutamatergic
hippocampal synapses of 4.1G/N double mutants is due to a
redundancy of these proteins with other 4.1 isoforms or with other
postsynaptic scaffold proteins. This notion is supported by the fact
that deletion of the only Drosophila 4.1 homologue (coracle), causes
the loss of coracle-binding GluRIIA receptors from postsynaptic
sites, whereas GluRIIB receptors, whose C-terminus does not bind
coracle, are not affected, indicating an important role of 4.1 proteins
in glutamate receptor anchoring at invertebrate synapses (Chen et
al., 2005). However, whether the same is true for mammalian 4.1
proteins will have to be determined in future genetic studies on
mice lacking all 4.1 proteins.
Materials and Methods
Generation of 4.1G/N double-mutant mice
For the generation of the 4.1N and the 4.1G single mutant mouse lines (Thomas and
Capecchi, 1987) we used genomic clones that had been isolated from a 129SV mouse
genomic λ FIXII library (Stratagene). DNA fragments of these clones were used to
construct the targeting vectors (Fig. 1A,D). The linearized DNAs of the 4.1N and
4.1G targeting vectors were electroporated into embryonic stem cells (E14), and
colonies were selected with G418 and Ganciclovir. Double-resistant clones were
analyzed by Southern blotting (Fig. 1B,E). Clones containing the recombined genes
were expanded and injected into mouse blastocysts to obtain highly chimeric mice
that transmitted the mutation through the germ line. Germ-line transmission was
confirmed by Southern blotting of tail-biopsy genomic DNA. Subsequently, routine
genotyping of DNA from tail biopsies was performed by PCR (Fig. 1C,F,G).
In vivo 3D MRI
WT and 4.1G/N double-mutant mice underwent MRI measurements at the age of 3
weeks and 7 months. All measurements were obtained at 2.35 T (Bruker BioSpin).
In vivo 3D T1-weighted (FLASH, TR/TE=17/7.58 mseconds, flip angle 25°) and
T2-weighted images (FSE, TR/TE=3000/60.95 mseconds, 8 echoes, inter-echo
spacing=14.4 mseconds) were acquired with an isotropic resolution of 117 μm and
a total measurement time of about 195 minutes per animal. The whole brain volume
(excluding brainstem), size of cerebellum and size of lateral ventricles were
determined in T1-weighted images by manually drawing respective regions of interests
on up to 50 contiguous horizontal MRI sections.
Immunostaining and light microscopic quantification
4-week-old wild-type and 4.1G/N double-mutant mice were deeply anesthetized with
tribromoethanol and perfused transcardially with 4% paraformaldehyde in 0.1 M PB
(sodium phosphate buffer, pH 7.4). Brains were removed and fixed overnight in 4%
paraformaldehyde, cryoprotected in sucrose and frozen on dry ice. Serial sagittal
cryostat sections (18 μm thick) were collected on slides and stored at –80°C until
used. After blocking in PB containing 5% normal goat serum and 0.25% Triton X-
100, the sections were stained using antibodies against VGLUT1/2 (both guinea-pig,
1:10,000, Chemicon) and ProSAP1 (Boeckers et al., 1999) (rabbit, 1:1000). The
sections were washed three times in PB and then incubated with Alexa Fluor 488-
or Alexa Fluor 555-labelled goat anti-guinea pig or goat anti-rabbit IgG secondary
antibodies (Molecular Probes) at room temperature. Coverslips were mounted with
Mowiol (Calbiochem). All images were acquired as single layers at zoom factor 2
using a Leica inverted confocal laser scanning microscope (DM IRE 2) with a 63
oil-immersion lens. To allow for intensity comparisons, the gain and offset were held
constant across images. Images were imported into the AnalySIS software (Soft-
Imaging Systems) and puncta within the hippocampal CA1 stratum radiatum were
quantified by touch-count analysis.
Ultrastructural analyses and quantification
Brains of 3-week-old mice were processed according to standard procedures. In brief,
mice were perfused with 4% paraformaldehyde and 0.25% glutaraldehyde in PBS.
Sections of hippocampus (2 mm thick) were washed, osmicated for 4 hours (1%
OsO4 in PBS), dehydrated through a graded series of ethanol and propylene oxide,
and embedded in Epon by polymerization for 12 hours at 60°C. Ultrathin sections
of the CA1 region were cut, contrasted with uranyl acetate and lead citrate, and
observed in a LEO 912AB transmission electron microscope (Zeiss). Digital images
were taken with a ProScan CCD camera and analyzed with CellP analysis software
(Olympus).
RNA isolation, RT-PCR and RNA-ligase-mediated (RLM)-RACE
Total RNA was isolated from WT and 4.1G/N double-mutant whole brains using the
RNeasy Lipid Tissue Kit (Qiagen). First-strand cDNA was synthesized with
Superscript III (Invitrogen) from adaptor-ligated RNA, which was obtained according
to the manual of the FirstChoice RLM-RACE Kit (Ambion). A gene-specific primer
or an oligo dT primer was utilized for this purpose. 5RACE of 4.1N was accomplished
according to the manual of the FirstChoice RLM-RACE Kit (Ambion). The 5RACE
was performed using two gene-specific nested primers as the reverse primers and
the kit provided nested primers (outer primer and inner primer) as the forward primers.
Both PCR reactions (outer and inner PCR) were performed at an annealing
temperature of 59°C. The amplified products of two different 5RACE gene-specific
primer combinations were purified using QIAquick Gel Extraction Kit (Qiagen),
cloned into pCR2.1TOPO (Invitrogen) and sequenced. The 3RACE of 4.1N was
carried out with two gene-specific nested primers as the forward primers and the
nested primers provided with the kit as the reverse primers. 3RACE PCR products
were analyzed as described above for the 5RACE. The sequences of primers are:
first strand synthesis primer, 5-CGTGGGCGTGGTGGTTTGA-3; gene-specific 5
RACE primers,
5-TCGGCATCATAGTCACCCAGTTCA-3; 5-CCAGAAGGGCATGCGTGA -
CAAAG-3; 5-TGCGCTCCCGATCCCAGTCT-3; 5-GATGCTGGCCTGGTGCT -
TC AAC-3; 5RACE outer primer, 5-GCT GAT GGC GAT GAA TGA ACA CTG-
3; 5RACE inner primer, 5-CGC GGA TCC GAA CAC TGC GTT TGC TGG
CTT TGA TG-3; gene-specific 3RACE primers, 5-CCTCAGTCAGTGAGA -
ATCACGATGC-3; 5-TGAAGGAGCCCAACAGCAAACT-3; 3RACE outer
primer, 5-GCG AGC ACA GAA TTA ATA CGA CT-3; 3RACE inner primer:
5-CGC GGA TCC GAA TTA ATA CGA CTC ACT ATA GG-3.
Western blotting and preparation of synaptosomal fractions
Synaptosomal fractions were prepared according to published protocols (Nicholls,
1978). For western blot sample preparation, olfactory bulbs, cortices, striata,
hippocampi, thalami, hypothalami, colliculi, cerebella, brain stems and spinal cords
from adult mouse brains were removed and homogenized in 320 mM sucrose, 5 mM
HEPES-NaOH (pH 7.4), 0.1 M EDTA (pH 8.0), 0.1 mM phenylmethylsulfonyl
fluoride, 1 μM aprotinin and 0.5 μM leupeptin. After determination of protein
concentrations, samples were diluted in SDS-PAGE sample buffer and analyzed
according to standard procedures (Laemmli, 1970; Towbin et al., 1992). For western
blot detection, the membranes were blocked for 30 minutes in Tris-buffered saline
(TBS), 0.1% Tween 20, containing 5% dry milk and 5% goat serum and incubated
with specific primary antibodies [anti-4.1G raised against the N-terminus in guinea-
pig; monoclonal anti-4.1N (BD Biosciences); anti-4.1N raised against the N-terminus
in guinea-pig; rabbit anti-4.1N detecting the CTD; mouse anti-GluR1 C3T (Upstate);
rabbit anti-GluR4 (Upstate); rabbit anti-GluR2/3 (Chemicon); mouse anti-NMDA-
NR1 M68 (Synaptic Systems)] diluted in blocking buffer, followed by the respective
horseradish peroxidase (HRP)-conjugated secondary antibody (Jackson
ImmunoResearch). Immunoreactive proteins were visualized by enhanced
chemiluminescence (ECL Plus system; Amersham Biosciences). For quantitative
western blot analyses, Alexa Fluor 680-coupled secondary antibodies were used and
the fluorescently labelled bands were quantified with the Odyssey Infrared imaging
system (Li-Cor Biosciences). Statistical analyses were performed using Student’s t-
test.
PSD preparation
3-week-old 4.1G/N double-mutant mice and WT control animals were sacrificed and
the hippocampi were isolated. The hippocampi of each animal were homogenized in
ten volumes of homogenisation buffer (320 mM sucrose, 20 mM HEPES-KOH (pH
7.4), 5 mM EDTA, 0.1 mM PMSF). The homogenate was centrifuged for 10 min at
1000 g. Supernatants S1 were recentrifuged for 10 minutes at 15,000 g, and the
resulting P2 pellets were resuspended in resuspension buffer (20 mM Tris-HCl pH
7.4, 2 mM EGTA, 1 mM PMSF). Protein concentration was determined by Bradford
assay. For solubilization, the protein concentration was set to 2 mg/ml, and Triton
X-100 was added to a final concentration of 1%. The samples were sonicated, followed
by agitation for 1 hour at 4°C. Extracts were centrifuged at 100,000 g for 1 hour.
The supernatant is the Triton-soluble fraction. The PSD-pellet (Triton-insoluble
fraction) was resuspended in 0.1 volume of 1% SDS, 2 mM EDTA, and 20 mM Tris-
HCl (pH 7.4). Then 0.9 volume of resuspension buffer was added and the samples
were agitated for 1 hour at 4°C. Protein concentration was determined by BCA assay.
25 μg protein was loaded per lane and analyzed by SDS-PAGE followed by western
blotting. Densitometric analysis was carried out using ImageJ software, and the signals
were normalized to β-tubulin signals. Significance was determined by Student’s t-
test.
Electrophysiology
WT and 4.1G/N double-mutant mice (3- to 5-weeks old) of both genders were
decapitated under anesthesia and the brains were quickly removed. Horizontal
hippocampal mouse brain slices (300 μm thick) were prepared in saccharose-based
ACSF containing 87 mM NaCl, 1.25 mM NaH2PO4, 2.5 mM KCl, 26 mM NaHCO3,
7 mM MgCl2, 0.5 mM CaCl2, 75 mM saccharose and 25 mM glucose. After incubation
for 30 minutes at 36°C, slices were transferred to physiological ACSF solution (119
mM NaCl, 1 mM NaH2PO4, 2.5 mM KCl, 1.3 mM MgSO4, 2.5 mM CaCl2, 26 mM
NaHCO3, 10 mM glucose, saturated with 95% O2 and 5% CO2 at pH 7.4) and kept













patch-clamp electrodes filled with ACSF. Field EPSPs were recorded in stratum
radiatum in area CA1. Schaffer collaterals were stimulated with a frequency of 0.05
Hz. Single cell recordings were performed in whole cell patch-clamp mode. Patch-
clamp electrodes (electrode resistance 2-5 MΩ) were filled with 117.5 mM Cs-
gluconate, 2.5 mM CsCl, 8 mM NaCl, 10 mM HEPES, 10.0 mM TEA, 0.2 mM
EGTA, 4 mM Mg-ATP, 0.3 mM Na3GTP and QX-314 2; pH was adjusted to 7.2
with CsOH. Access resistance ranged from 6 to 20 MΩ and was continuously
monitored throughout the experiment. Recordings were discarded when the series
resistance changed more than 20%. All patch-clamp experiments were done in the
presence of the GABAA receptor-antagonist gabazine (SR 95531, 1 μM; Sigma) and
4 mM MgSO4 and CaCl2. AMPA/NMDA ratios were obtained by evoking single-
component EPSCs at –60 mV and a dual-component EPSCs at +40 mV. The NMDA-
mediated portion of the dual-component current at +40 mV was measured 100
mseconds after the stimulation artefact. AMPAR-rectification index was determined
(in the presence of 40 μM APV) as current amplitude at a holding potential of –60
mV divided by the amplitude at + 40 mV. Miniature EPSCs were recorded in the
presence of tetrodotoxin (TTX, 1 μM) and cyclothiazide (100 μM). AMPA-mediated
whole-cell currents were obtained by bath application of 100 nM S-AMPA for five
minutes in the presence of TTX and cyclothiazide. In field recordings, LTP was
induced by four tetani of high-frequency stimulation at 100 Hz for 1 second with 20
second intertrain intervals. The magnitude of LTP was determined by averaging the
responses collected during the last 5 minutes of each experiment. Paired-pulse
facilitation (P2/P1) in the field and whole-cell recordings was investigated by analysing
the ratio of second the first synaptic response. Data are expressed as mean ± s.e.m.,
and statistical comparison was done by applying Student’s t-test (Excel, Microsoft).
The significance level was set to P<0.05.
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